Medical Students and Risk of COVID-19 Infection

This study aims to estimate the prevalence of infected medical students with COVID-19 in the University of Jordan and to compare number of cases between students in clinical and basic years. In addition, this can provide insight into the awareness of infection control practices among students. Furthermore, to examine if hospital rotations increased risk of infection between clinical year medical students.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

The University of Jordan

Amman, 11942, Jordan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All medical Students

Exclusion criteria

none

Treatment and study plan

No intervention, questioner only

Other

questioner only

Primary outcomes

COVID 19 infection

Time frame: 3 months

Incidence of Infected students with Covid 19

Sponsors and collaborators

Lead sponsor

University of Jordan

Other

Registry information

Official study title

Medical Students and Risk of COVID-19 Infection: a Descriptive Study From the University of Jordan

Acronym: Covid 19

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Jul 19, 2021
Registry last updated: Jul 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed